Marion Frederick Hawthorne

Columbia, MO, United States of America

Marion Frederick Hawthorne

wikipedia

This inventor holds 27 USPTO granted patents and 2 published patent applications and 1 EPO patent, primarily in Boron Chemistry. Top assignees: University of California, University of Missouri, Coremetals Research, Inc.. Active years: 1976-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marion Frederick Hawthorne. Retrieved from https://idiyas.com/inventor/marion-frederick-hawthorne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 27 

% Patents Active = 81.5

 

Average Co-Inventor Count = 2.0

ph-index = 6

Forward Citations = 254(Granted Patents)


Location History:

  • Brentwood, CA (US) (1976)
  • Huntsville, AL (US) (1976 - 1977)
  • Los Angeles, CA (US) (1977 - 1991)
  • Encino, CA (US) (1982 - 2003)
  • Columbia, MO (US) (2014 - 2019)

Company Filing History:


Years Active: 1976-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Boron Compounds
Neuromuscular Agents
Neutron-Capture Therapy
Macromolecular Structures
Antibody Conjugates
Metallocarborane
Polyhedral Boranes
Synthesis Processes
Ion-Selective Membranes
High Energy Propellants
Boron Delivery
Hydridometallic Catalysts
27 patents (USPTO):Explore Patents

Title: Marion Frederick Hawthorne: Innovator in Neuromuscular Pharmacology

Introduction

Marion Frederick Hawthorne, based in Columbia, Missouri, has made significant contributions to the field of pharmacology through his innovative work. With a total of six patents to his name, Hawthorne's research primarily focuses on neuromuscular blocking agents, showcasing his dedication to advancing medical science.

Latest Patents

Hawthorne's recent patents demonstrate his expertise in developing novel pharmaceutical compounds. One of his latest inventions involves neuromuscular blocking agents, which are based on carborane derivatives. These compounds are designed for use as effective neuromuscular blockers, featuring unique cationic functional groups that enhance their efficacy. Another of his notable patents involves cluster boron compounds, which serve as sodium channel blockers. This innovation provides not only new methods for their production but also insights into their potential therapeutic applications.

Career Highlights

Hawthorne has established a successful career at the University of Missouri, where he has focused on researching and developing new pharmaceutical agents. His work is characterized by a strong commitment to scientific inquiry and a passion for improving healthcare outcomes.

Collaborations

Throughout his career, Hawthorne has collaborated with esteemed colleagues, including George R. Kracke and Yulia Sevryugina. These partnerships have played a crucial role in advancing his research and enhancing the impact of his innovations.

Conclusion

Marion Frederick Hawthorne stands out as a prominent inventor in the field of pharmacology. His six patents reflect a robust body of work that continues to influence medical practices. As he paves the way for future innovations, his contributions are sure to leave a lasting legacy in the realm of neuromuscular pharmacology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…